SurModics, Inc. Receives ISO Certification

July 13, 2004 at 4:01 PM EDT

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--July 13, 2004--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery solutions to the medical device industry, today announced that its Quality Management System has been certified according to procedures listed in ISO 9001:2000 and EN ISO 13485:2000.

"We are pleased to receive this ISO certification," said Bruce Barclay, President and COO. "SurModics takes quality very seriously in all aspects of its operations, including product development, marketing, production, and distribution activities."

The ISO application process takes considerable time and preparation, culminating in a rigorous review by an independent Notified Body. Adoption of International Standards means that SurModics adheres to the world's most stringent quality standards. For our customers, conformity of products and services to these standards provides assurance of quality, safety, and reliability.

The ISO 9001:2000 and EN ISO 13485:2000 certificates of registration were awarded by TUV Rheinland of North America, Inc., a leading International Standards Organization (ISO) registrar, following an extensive audit of the Company's quality systems. According to Barclay, the audit confirmed the Company's compliance with all applicable international standards for quality systems. "Our receipt of this Certification is an important milestone for SurModics and will directly benefit our customers well into the future," he said.

About SurModics, Inc.

SurModics, Inc., a leading provider of surface modification and drug delivery solutions, licenses its patented technologies to medical device, diagnostics, and biotechnology companies around the world. A significant portion of SurModics' revenue is generated through royalties on the sale of coated products. A copy of our certifications can be found on SurModics' web site at

    CONTACT: SurModics, Inc., Eden Prairie
             Phil Ankeny, 952-829-2700

    SOURCE: SurModics, Inc.